Microfluidic Chip for Leukocyte Adhesion Cascade Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro models fail to simultaneously study leukocyte rolling, adhesion, and migration due to limitations in modeling physiological shear and real-time visualization, hindering the understanding of the leukocyte adhesion cascade and anti-inflammatory drug development.
Innovation Solution
A microfluidic chip with idealized flow channels and tissue spaces, featuring porous walls and a synthetic or idealized microvascular network, allows for the study of leukocyte rolling, adhesion, and migration under controlled fluid shear conditions, enabling real-time visualization and quantitative measurement.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If flow chambers are used to study rolling and adhesion phenomena, then physiological shear is provided, but transmigration cannot be modeled
Solution Approach 1:
The microfluidic device is segmented into distinct functional zones: an upper flow chamber for rolling/adhesion studies and a lower transwell chamber for transmigration studies. This segmentation allows each zone to be optimized for its specific function while maintaining physiological shear conditions throughout the system.
Solution Approach 2:
The microfluidic device integrates multiple functions into a single system: it can simultaneously perform rolling/adhesion studies in the flow chamber and transmigration studies in the transwell chamber, both under controlled physiological shear conditions. This multi-functionality resolves the contradiction by enabling both previously separate capabilities in one device.
2Productivity
If Transwell and Boyden chambers are used for migration studies, then migration can be measured, but fluid shear and size/topology observed in vivo cannot be accounted for
Solution Approach 1:
The device uses a microfluidic pump system to generate controlled fluid flow through the transwell chamber, creating physiological shear conditions that mimic in vivo environments. This hydraulic control allows migration studies to be performed under realistic flow conditions rather than static conditions.
Solution Approach 2:
The microfluidic system allows dynamic adjustment of flow rate parameters to match physiological shear rates observed in vivo. By controlling the fluid flow parameters, the device can replicate the size, topology, and shear conditions of real microvascular environments while maintaining migration measurement capabilities.
3Device complexity
If current experimental models are used, then individual aspects of leukocyte adhesion cascade can be studied, but rolling, adhesion and migration cannot be resolved in a single in vitro assay
Solution Approach 1:
The device merges previously separate flow chamber and transwell chamber functionalities into a single integrated microfluidic system. This allows rolling, adhesion, and migration processes to be studied sequentially and simultaneously in one continuous experiment under controlled physiological conditions, eliminating the need for multiple separate assays.
Data Source
AI summary
Methods of assaying the leukocyte adhesion cascade (LAC) and monitoring leukocyte rolling, adhesion, and/or migration can be implemented with an apparatus that includes an idealized microvascular network (IMN) of one or more interconnected idealized flow channels in fluid communication through a porous wall with a tissue space (e.g., idealized tissue space). The methods of assaying the LAC can be implemented with means for quantifying modulation of the leukocyte adhesion cascade. Methods of assaying the LAC can be implemented with the device and one or more active agents to monitor leukocyte rolling, adhesion, and/or migration in the presence of absence of the active agent. Migration can be through the idealized flow channels, through the porous wall, and/or into the tissue space.